Corrigendum to “Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells” [Biochem. Pharmacol. 227 (2024) 116445]
Titel:
Corrigendum to “Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells” [Biochem. Pharmacol. 227 (2024) 116445]
Auteur:
De Vos, Kristof Mavrogiannis, Adamantios Wolters, Justina Clarinda Schlenner, Susan Wierda, Keimpe Calabuig, Álvaro Cortés Chinnaraj, Reena Dermesrobian, Vera Armoudjian, Yeghig Jacquemyn, Maarten Corthout, Nikky Daelemans, Dirk Annaert, Pieter